These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22923740

  • 1. Depletion of glutamine enhances sodium butyrate-induced erythroid differentiation of K562 cells.
    Canh Hiep N, Kinohira S, Furuyama K, Taketani S.
    J Biochem; 2012 Dec; 152(6):509-19. PubMed ID: 22923740
    [Abstract] [Full Text] [Related]

  • 2. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
    Tahara T, Sun J, Igarashi K, Taketani S.
    Biochem Biophys Res Commun; 2004 Nov 05; 324(1):77-85. PubMed ID: 15464985
    [Abstract] [Full Text] [Related]

  • 3. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W, Zwanzger D, Borkhardt A.
    Cell Biol Int; 2004 Nov 05; 28(5):403-10. PubMed ID: 15193284
    [Abstract] [Full Text] [Related]

  • 4. Possible interaction between B1 retrotransposon-containing sequences and β(major) globin gene transcriptional activation during MEL cell erythroid differentiation.
    Vizirianakis IS, Tezias SS, Amanatiadou EP, Tsiftsoglou AS.
    Cell Biol Int; 2012 Jan 05; 36(1):47-55. PubMed ID: 21970403
    [Abstract] [Full Text] [Related]

  • 5. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH.
    Acta Pharmacol Sin; 2004 Feb 05; 25(2):231-8. PubMed ID: 14769215
    [Abstract] [Full Text] [Related]

  • 6. Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway.
    Lee WH, Chung MH, Tsai YH, Chang JL, Huang HM.
    Am J Physiol Cell Physiol; 2014 Feb 15; 306(4):C407-14. PubMed ID: 24336657
    [Abstract] [Full Text] [Related]

  • 7. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA, Yazdanparast R, Lotfi A.
    Int J Biochem Cell Biol; 2007 Feb 15; 39(9):1685-97. PubMed ID: 17543571
    [Abstract] [Full Text] [Related]

  • 8. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
    Qian X, Chen J, Zhao D, Guo L, Qian X.
    Int J Mol Med; 2013 Jun 15; 31(6):1418-28. PubMed ID: 23588991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
    Li Y, Wu XR, Li XF, Suriguga, Yu CH, Li YR, Yi ZC.
    Toxicology; 2013 Oct 04; 312():108-14. PubMed ID: 23973255
    [Abstract] [Full Text] [Related]

  • 11. Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.
    Huang HM, Li YC, Chung MH.
    J Cell Physiol; 2010 Jun 04; 223(3):687-94. PubMed ID: 20162623
    [Abstract] [Full Text] [Related]

  • 12. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
    Kucukkaya B, Arslan DO, Kan B.
    Life Sci; 2006 Feb 09; 78(11):1217-24. PubMed ID: 16216279
    [Abstract] [Full Text] [Related]

  • 13. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
    Dupont C, Couillerot E, Gillet R, Caron C, Zeches-Hanrot M, Riou JF, Trentesaux C.
    Planta Med; 2005 Jun 09; 71(6):489-94. PubMed ID: 15971117
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM, Chiou HY, Chang JL.
    J Cell Biochem; 2006 Jul 01; 98(4):789-97. PubMed ID: 16440334
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, Reuter S, Dicato M, Diederich M.
    Biochem Pharmacol; 2008 Nov 15; 76(10):1229-39. PubMed ID: 18805401
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
    Morceau F, Schnekenburger M, Blasius R, Buck I, Dicato M, Diederich M.
    Cancer Lett; 2006 Aug 28; 240(2):203-12. PubMed ID: 16274927
    [Abstract] [Full Text] [Related]

  • 18. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
    Zein S, Li W, Ramakrishnan V, Lou TF, Sivanand S, Mackie A, Pace B.
    Exp Biol Med (Maywood); 2010 Nov 28; 235(11):1385-94. PubMed ID: 20975082
    [Abstract] [Full Text] [Related]

  • 19. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
    Szulawska A, Arkusinska J, Czyz M.
    Biochem Pharmacol; 2007 Jan 15; 73(2):175-84. PubMed ID: 17097070
    [Abstract] [Full Text] [Related]

  • 20. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways.
    Witt O, Sand K, Pekrun A.
    Blood; 2000 Apr 01; 95(7):2391-6. PubMed ID: 10733512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.